PAMU
FATE icon

Pictet Asset Management (UK)’s Fate Therapeutics FATE Stock Holding History

Pictet Asset Management (UK)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$73.6M Buy
847,723
+108,741
+15% +$8.76M 0.08% 276
2021
Q1 		$60.9M Buy
738,982
+146,729
+25% +$14.1M 0.07% 293
2020
Q4 		$53.9M Sell
592,253
-725,747
-55% -$45.1M 0.07% 294
2020
Q3 		$52.7M Buy
1,318,000
+20,221
+2% +$706K 0.08% 267
2020
Q2 		$44.5M Buy
1,297,779
+731,467
+129% +$21.8M 0.08% 268
2020
Q1 		$12.6M Sell
566,312
-667,285
-54% -$16.9M 0.03% 435
2019
Q4 		$24.1M Buy
1,233,597
+112,479
+10% +$1.79M 0.04% 398
2019
Q3 		$17.4M Buy
1,121,118
+775,700
+225% +$14.9M 0.04% 419
2019
Q2 		$7.01M Buy
+345,418
New +$6.22M 0.02% 610

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (UK)'s FATE Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Fate Therapeutics (FATE) stake by 15% in Q2 2021, buying an estimated $8.76M and bringing the position to 847,723 shares worth $73.6M. The position accounts for 0.08% of the portfolio, ranked #276.

Pictet Asset Management (UK) first reported a position in FATE in Q2 2019 and has held it in 9 quarters since. 272 funds tracked by Wall St. Rank hold FATE as of Q2 2021.

  • Pictet Asset Management (UK) held 847,723 shares of Fate Therapeutics worth $73.6M as of Q2 2021.
  • Pictet Asset Management (UK) bought 108,741 Fate Therapeutics shares in Q2 2021, an estimated $8.76M.
  • Fate Therapeutics made up 0.08% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #276 holding.
  • Pictet Asset Management (UK) first reported a position in Fate Therapeutics in Q2 2019 and has held it in 9 quarters since.
  • 272 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.